Discover

IRWD
Ironwood Pharmaceuticals, Inc.
4.12
2 x 3.89
1 x 4.70
bid
ask
-
0.09
2.14%
2 @ 04:00 PM
4.09 -0.03 (0.73%)
Ytd22.26%
1y488.57%
4.06
day range
4.29
0.67
52 week range
5.78
Open4.14Prev Close4.21Low4.06High4.29Mkt Cap678.21M
Vol1.65MAvg Vol2.29MEPS0.62P/E6.65Forward P/E12.08
Beta0.47Short Ratio6.73Inst. Own105.29%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg3.85200-d Avg3.381yr Est12.50
Income Statement
Total Revenue106.51M
Revenues (USD)106.51M
Gross Profit106.51M
Operating Expenses33.93M
Research and Development Expense21.94M
Selling, General and Administrative Expense12.03M
Operating Income72.57M
Interest Expense9.14M
Income Tax Expense24.40M
Net Income40.77M
Net Income Common Stock40.77M
Net Income Common Stock (USD)40.77M
Consolidated Income40.77M
Earnings per Basic Share0.25
Earnings per Basic Share (USD)0.25
Earnings per Diluted Share0.24
Earning Before Interest & Taxes (EBIT)74.31M
Earning Before Interest & Taxes (USD)74.31M
Weighted Average Shares163.45M
Weighted Average Shares Diluted166.69M
Balance Sheet
Cash and Equivalents220.47M
Cash and Equivalents (USD)220.47M
Trade and Non-Trade Receivables105.84M
Current Assets332.29M
Property, Plant & Equipment Net12.06M
Total Assets434.57M
Debt Current203.12M
Total Debt597.36M
Current Liabilities236.31M
Debt Non-Current394.23M
Total Liabilities651.71M
Accumulated Retained Earnings (Deficit)-1.63B
Accumulated Other Comprehensive Income-795.00K
Shareholders Equity-217.14M
Shareholders Equity (USD)-217.14M
Assets Non-Current102.27M
Total Debt (USD)597.36M
Goodwill and Intangible Assets1.84M
Liabilities Non-Current415.40M
Trade and Non-Trade Payables3.24M
Tax Assets84.24M
Cash Flow
Depreciation, Amortization & Accretion887.00K
Net Cash Flow / Change in Cash & Cash Equivalents5.01M
Net Cash Flow from Operations5.12M
Effect of Exchange Rate Changes on Cash -106.00K
Share Based Compensation3.65M